Skip to main content
Clinical Trials/DRKS00032851
DRKS00032851
Completed
未知

KNEIPP therapy for hypertension with special consideration of hydrotherapy in the home setting

niversität Witten/Herdecke, Gemeinschaftskrankenhaus Herdecke0 sites110 target enrollmentOctober 19, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
arterial hypertension (high normal, grade I, grade II)
Sponsor
niversität Witten/Herdecke, Gemeinschaftskrankenhaus Herdecke
Enrollment
110
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 19, 2023
End Date
April 1, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversität Witten/Herdecke, Gemeinschaftskrankenhaus Herdecke

Eligibility Criteria

Inclusion Criteria

  • arterial hypertension (high normal, grade I, grade II) in 24h blood pressure monitoring

Exclusion Criteria

  • pAVK IIb\- IV
  • Recent myocardial infarction in the last 6 months
  • Chronic renal insufficiency from stage III onwards
  • Cortisone therapy
  • Advanced heart failure NYHA III and IV
  • Unstable CHD
  • Patients not able to give consent
  • Advanced mobility impairment
  • Pregnant women
  • Acute severe infections

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Role of homeopathy in essential hypertensio
CTRI/2023/05/052409Bakson Homoeopathic Medical College and Hospital
Completed
Not Applicable
STEPWISE treatment of uncontrolled HyperTensioN in primary care: a cluster randomised trial.
NL-OMON50648Julius Centrum240
Active, not recruiting
Phase 1
THE TREATMENT OF HYPERTENSION ASSOCIATED WITH SEVERE PREECLAMPSIA.A RANDOMIZED CONTROLLED TRIAL OF URAPIDIL VERSUS NICARDIPINE.The URANIC trial.Hypertension associated with severe pre eclampsiaTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
EUCTR2014-002544-40-FRHôpitaux Universitaires de Strasbourg366
Completed
Not Applicable
A novel approach to treatment of hypertension in diabetic patients - A multicenter, double-blind, randomised study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design.Essential Hypertension grade I and IICirculatory SystemHypertension
ISRCTN55725285Solvay Pharmaceuticals (Germany)
Active, not recruiting
Phase 1
Seeking the ideal anti-hypertensive therapy in obesity-related hypertension. An open-label, single center, randomized clinical trial.obesity linked hypertensionMedDRA version: 19.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2016-000571-25-ESFundació Clinic per a la Recerca Biomèdica